BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30982971)

  • 1. Tspan8 is expressed in breast cancer and regulates E-cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesicles.
    Voglstaetter M; Thomsen AR; Nouvel J; Koch A; Jank P; Navarro EG; Gainey-Schleicher T; Khanduri R; Groß A; Rossner F; Blaue C; Franz CM; Veil M; Puetz G; Hippe A; Dindorf J; Kashef J; Thiele W; Homey B; Greco C; Boucheix C; Baur A; Erbes T; Waller CF; Follo M; Hossein G; Sers C; Sleeman J; Nazarenko I
    J Pathol; 2019 Aug; 248(4):421-437. PubMed ID: 30982971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-Evaluating E-Cadherin and β-Catenin: A Pan-Cancer Proteomic Approach with an Emphasis on Breast Cancer.
    Borcherding N; Cole K; Kluz P; Jorgensen M; Kolb R; Bellizzi A; Zhang W
    Am J Pathol; 2018 Aug; 188(8):1910-1920. PubMed ID: 29879416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
    de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
    J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of adhesion proteins E-cadherin, alpha-catenin, beta-catenin and gamma-catenin is different in T1 and T2 breast tumours.
    Bukholm IR; Nesland JM; Bukholm G
    Pathology; 2006 Oct; 38(5):403-7. PubMed ID: 17008277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast].
    Han A; Xiong M; Li Z; Liang Y
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):27-30. PubMed ID: 11866953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study.
    Rakha EA; Teoh TK; Lee AH; Nolan CC; Ellis IO; Green AR
    Histopathology; 2013 Apr; 62(5):695-701. PubMed ID: 23347178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High TSPAN8 expression in epithelial cancer cell-derived small extracellular vesicles promote confined diffusion and pronounced uptake.
    Wang T; Wang X; Wang H; Li L; Zhang C; Xiang R; Tan X; Li Z; Jiang C; Zheng L; Xiao L; Yue S
    J Extracell Vesicles; 2021 Nov; 10(13):e12167. PubMed ID: 34796683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression pattern of E-cadherin and p120-catenin in infiltrating lobular carcinoma and ductal carcinoma of the breast and its significance].
    Li L; Bi XF; Xu X; Liu XY; Shen GH; Guo L; Yuan YL; Wang F; Wang MR; Yang HY
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):273-7. PubMed ID: 20510078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma.
    Choi YJ; Pinto MM; Hao L; Riba AK
    Mod Pathol; 2008 Oct; 21(10):1224-37. PubMed ID: 18587329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
    Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
    Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
    Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
    Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis?
    Kwaepila N; Burns G; Leong AS
    Pathology; 2006 Apr; 38(2):125-31. PubMed ID: 16581652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions.
    Sarrió D; Pérez-Mies B; Hardisson D; Moreno-Bueno G; Suárez A; Cano A; Martín-Pérez J; Gamallo C; Palacios J
    Oncogene; 2004 Apr; 23(19):3272-83. PubMed ID: 15077190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
    McCart Reed AE; Kutasovic JR; Nones K; Saunus JM; Da Silva L; Newell F; Kazakoff S; Melville L; Jayanthan J; Vargas AC; Reid LE; Beesley J; Chen XQ; Patch AM; Clouston D; Porter A; Evans E; Pearson JV; Chenevix-Trench G; Cummings MC; Waddell N; Lakhani SR; Simpson PT
    J Pathol; 2018 Apr; 244(4):460-468. PubMed ID: 29344954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance].
    Ma YH; Wang K; Li L; Lu ZH; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):5-9. PubMed ID: 20388391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer.
    Dubois-Marshall S; Thomas JS; Faratian D; Harrison DJ; Katz E
    Clin Exp Metastasis; 2011 Dec; 28(8):811-8. PubMed ID: 21789718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
    McCart Reed AE; Kutasovic JR; Vargas AC; Jayanthan J; Al-Murrani A; Reid LE; Chambers R; Da Silva L; Melville L; Evans E; Porter A; Papadimos D; Thompson EW; Lakhani SR; Simpson PT
    J Pathol; 2016 Mar; 238(4):489-94. PubMed ID: 26510554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.